Augustine Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.13M | Sell |
48,484
-449
| -0.9% | -$59.2K | 1.24% | 17 |
|
|
2026
Q1 | $6.82M | Buy |
48,933
+1
| +0% | +$140 | 1.54% | 13 |
|
|
2025
Q4 | $6.01M | Sell |
48,932
-187
| -0.4% | -$22.7K | 1.2% | 13 |
|
|
2025
Q3 | $5.45M | Sell |
49,119
-174
| -0.4% | -$19.8K | 1.1% | 14 |
|
|
2025
Q2 | $5.47M | Buy |
49,293
+560
| +1% | +$59.6K | 1.46% | 13 |
|
|
2025
Q1 | $5.46M | Sell |
48,733
-3,113
| -6% | -$321K | 1.6% | 13 |
|
|
2024
Q4 | $4.79M | Sell |
51,846
-1,436
| -3% | -$129K | 1.26% | 14 |
|
|
2024
Q3 | $4.47M | Buy |
53,282
+269
| +0.5% | +$20.5K | 1.56% | 16 |
|
|
2024
Q2 | $3.64M | Buy |
53,013
+271
| +0.5% | +$18.1K | 1.4% | 19 |
|
|
2024
Q1 | $3.86M | Sell |
52,742
-458
| -0.9% | -$35.2K | 1.61% | 17 |
|
|
2023
Q4 | $4.31M | Buy |
53,200
+2,110
| +4% | +$164K | 1.91% | 13 |
|
|
2023
Q3 | $3.83M | Sell |
51,090
-1,396
| -3% | -$107K | 1.77% | 13 |
|
|
2023
Q2 | $4.05M | Buy |
52,486
+11
| +0% | +$877 | 1.87% | 14 |
|
|
2023
Q1 | $4.35M | Sell |
52,475
-342
| -0.6% | -$28.3K | 2.16% | 14 |
|
|
2022
Q4 | $4.53M | Sell |
52,817
-1,185
| -2% | -$93.8K | 2.51% | 12 |
|
|
2022
Q3 | $3.33M | Buy |
54,002
+2,011
| +4% | +$127K | 2.19% | 14 |
|
|
2022
Q2 | $3.21M | Sell |
51,991
-4,519
| -8% | -$280K | 1.97% | 16 |
|
|
2022
Q1 | $3.36M | Buy |
56,510
+106
| +0.2% | +$6.78K | 1.69% | 20 |
|
|
2021
Q4 | $4.09M | Sell |
56,404
-107
| -0.2% | -$7.37K | 2.01% | 16 |
|
|
2021
Q3 | $3.95M | Sell |
56,511
-204
| -0.4% | -$14.3K | 2.1% | 14 |
|
|
2021
Q2 | $3.9M | Sell |
56,715
-2,090
| -4% | -$140K | 2.01% | 17 |
|
|
2021
Q1 | $3.8M | Sell |
58,805
-106
| -0.2% | -$6.83K | 2% | 14 |
|
|
2020
Q4 | $3.43M | Sell |
58,911
-3,905
| -6% | -$236K | 1.78% | 17 |
|
|
2020
Q3 | $3.97M | Sell |
62,816
-3,194
| -5% | -$221K | 2.33% | 13 |
|
|
2020
Q2 | $5.08M | Sell |
66,010
-292
| -0.4% | -$22.4K | 3.07% | 8 |
|
|
2020
Q1 | $4.96M | Buy |
66,302
+4,275
| +7% | +$295K | 3.51% | 8 |
|
|
2019
Q4 | $4.03M | Buy |
62,027
+3,721
| +6% | +$242K | 2.44% | 13 |
|
|
2019
Q3 | $3.69M | Sell |
58,306
-235
| -0.4% | -$15.4K | 2.49% | 16 |
|
|
2019
Q2 | $3.96M | Buy |
58,541
+393
| +0.7% | +$25.9K | 2.72% | 12 |
|
|
2019
Q1 | $3.78M | Buy |
58,148
+5,969
| +11% | +$397K | 2.51% | 13 |
|
|
2018
Q4 | $3.26M | Sell |
52,179
-2,287
| -4% | -$160K | 2.23% | 16 |
|
|
2018
Q3 | $4.21M | Sell |
54,466
-214
| -0.4% | -$16.2K | 2.33% | 15 |
|
|
2018
Q2 | $3.87M | Buy |
54,680
+750
| +1% | +$53K | 2.26% | 18 |
|
|
2018
Q1 | $4.07M | Buy |
53,930
+9,582
| +22% | +$762K | 2.32% | 17 |
|
|
2017
Q4 | $3.18M | Sell |
44,348
-6,810
| -13% | -$517K | 1.8% | 22 |
|
|
2017
Q3 | $4.14M | Buy |
+51,158
| New | +$3.91M | 2.65% | 12 |
|
Other funds holding GILD
LMFP
CIM
ATO
CGH
Augustine Asset Management's GILD Position: Q2 2026 in Review
Augustine Asset Management reduced its Gilead Sciences (GILD) stake by 0.92% in Q2 2026, selling an estimated $59.2K and leaving 48,484 shares worth $6.13M. The position accounts for 1.24% of the portfolio, ranked #17.
Augustine Asset Management first reported a position in GILD in Q3 2017 and has held it in 36 quarters since. The position peaked at $6.82M in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Augustine Asset Management held 48,484 shares of Gilead Sciences worth $6.13M as of Q2 2026.
- Augustine Asset Management sold 449 Gilead Sciences shares in Q2 2026, an estimated $59.2K.
- Gilead Sciences made up 1.24% of Augustine Asset Management's portfolio in Q2 2026, its #17 holding.
- Augustine Asset Management first reported a position in Gilead Sciences in Q3 2017 and has held it in 36 quarters since.
- Augustine Asset Management's Gilead Sciences position peaked at $6.82M in Q1 2026.
- 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Augustine Asset Management's 13F filing for Q2 2026, filed 13 Jul 2026.